Borderline Ductal Epithelial Lesions: Interobserver Reproducibility in 43 Cases with Original Diagnosis of Atypical Ductal Hyperplasia Bordering on Ductal Carcinoma In-Situ

被引:0
|
作者
Tozbikian, G.
Brogi, E.
Catalano, J.
Patil, S.
Van Zee, K. J.
Kadivar, M.
Vallejo, C. E.
Wen, Y. H.
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Univ Tehran Med Sci, Rasool Akram Hosp, Tehran, Iran
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
291
引用
收藏
页码:72A / 72A
页数:1
相关论文
共 50 条
  • [41] Flat Epithelial Atypia and Atypical Ductal Hyperplasia: Carcinoma Underestimation Rate
    Ingegnoli, Anna
    d'Aloia, Cecilia
    Frattaruolo, Antonia
    Pallavera, Lara
    Martella, Eugenia
    Crisi, Girolamo
    Zompatori, Maurizio
    BREAST JOURNAL, 2010, 16 (01): : 55 - 59
  • [42] Spindle cell ductal carcinoma in situ - An unusual variant of ductal intra-epithelial neoplasia that simulates ductal hyperplasia or a myoepithelial proliferation
    Farshid, G
    Moinfar, F
    Meredith, DJ
    Peiterse, S
    Tavassoli, FA
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 2001, 439 (01): : 70 - 77
  • [43] Outcomes of Tamoxifen Treatment Alone in Patients With Ductal Carcinoma In Situ or Atypical Ductal Hyperplasia Who Refused Surgery
    Kwak, Youngji
    Ryu, Jai Min
    Chae, Byung Joo
    Yu, Jonghan
    Kim, Seok Won
    Nam, Seok Jin
    Lee, Jeong Eon
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2024, 2024
  • [44] Atypical Ductal Hyperplasia and Those Boarding on Ductal Carcinoma in Situ Should be Included in the Active Surveillance Clinical Trials
    Khoury, Thaer
    Jabbour, Nashwan
    Peng, Xuan
    Yan, Li
    Quinn, Marie
    MODERN PATHOLOGY, 2019, 32
  • [45] Atypical Ductal Hyperplasia and Those Boarding on Ductal Carcinoma in Situ Should be Included in the Active Surveillance Clinical Trials
    Khoury, Thaer
    Jabbour, Nashwan
    Peng, Xuan
    Yan, Li
    Quinn, Marie
    LABORATORY INVESTIGATION, 2019, 99
  • [46] Thymidine kinase 1 expression in atypical ductal hyperplasia significantly differs from usual ductal hyperplasia and ductal carcinoma in situ: A useful tool in tumor therapy management
    Guan, Hong
    Sun, Yanhua
    Zan, Qin
    Xu, Meiquan
    Li, Yuan
    Zhou, Ji
    He, Ellen
    Eriksson, Staffan
    Wen, Wen
    Skog, Sven
    MOLECULAR MEDICINE REPORTS, 2009, 2 (06) : 923 - 929
  • [47] INTEROBSERVER REPRODUCIBILITY IN THE DIAGNOSIS OF DUCTAL PROLIFERATIVE BREAST-LESIONS USING STANDARDIZED CRITERIA
    SCHNITT, SJ
    CONNOLLY, JL
    TAVASSOLI, FA
    FECHNER, RE
    KEMPSON, RL
    GELMAN, R
    PAGE, DL
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1992, 16 (12) : 1133 - 1143
  • [48] The diagnosis and management of pre-invasive breast disease: Ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH) – current definitions and classification
    Sarah E Pinder
    Ian O Ellis
    Breast Cancer Research, 5
  • [49] Interobserver reproducibility (IR) of the Lagios nuclear grading system for ductal carcinoma in situ (DCIS)
    Sneige, N
    Lagios, M
    Schwarting, R
    Colburn, W
    Atkinson, E
    Weber, D
    Risin, S
    Sahin, A
    Kemp, B
    Boone, C
    Dhingra, K
    Kelloff, G
    Lippman, S
    MODERN PATHOLOGY, 1998, 11 (01) : 28A - 28A
  • [50] The diagnosis and management of pre-invasive breast disease -: Ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH) -: current definitions and classification
    Pinder, SE
    Ellis, IO
    BREAST CANCER RESEARCH, 2003, 5 (05): : 254 - 257